10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 258 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,059,039 | -16.3% | 620,002 | +61.6% | 0.02% | -17.4% |
| Q1 2024 | $14,400,411 | +1415.0% | 383,704 | +2154.2% | 0.02% | +666.7% |
| Q2 2023 | $950,508 | -22.6% | 17,022 | -49.5% | 0.00% | -57.1% |
| Q4 2022 | $1,227,919 | -53.8% | 33,697 | +148.3% | 0.01% | -76.7% |
| Q2 2021 | $2,658,000 | +12.5% | 13,573 | -18.7% | 0.03% | -11.8% |
| Q4 2020 | $2,363,000 | +325.0% | 16,685 | +274.3% | 0.03% | +325.0% |
| Q3 2020 | $556,000 | – | 4,458 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |